TEMPO.CO, Jakarta - Spokesman of state-owned pharmaceutical holding firm PT Bio Farma Bambang Heriyanto said the arrival of 11 million doses of Covid-19 vaccine from Sinovac in the form of bulk raw materials is part of the 140 million doses planned to be imported this year.
"The arrival [of vaccine raw materials] today will be processed on February 13 and is expected to finish on March 20, 2021," said Bambang in a live broadcast on Tuesday, February 2.
The government had received 15 million doses of vaccine raw materials in mid-January and the firm had started the production. “It is estimated to complete on February 11, 2021."
The raw materials processed into finished products would go through a series of quality tests by the firm's laboratory and the Food and Drug Monitoring Agency (BPOM).
"BPOM will issue the test result in the form of lot releases for vaccines produced by Bio Farma, and the first batch is predicted to finish in the second week of February 2021," Bambang explained.
The ready-to-use vaccines would be used on public officials including the Indonesian Military and National Police personnel starting at the end of February 2021. Bambang ensured that the distribution scheme could maintain the quality of the Covid-19 vaccine.
"Bio Farma adopts the Vaccine Distribution Management System (SMDV) equipped with IoT technology," Bambang said.